Patent · US Active

Materials and methods to potentiate cancer treatment

US8242115B2 · kind B2 · utility

0Cited by
14References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 16, 2007
Grant dateAug 14, 2012
Priority date
Expiry dateFeb 16, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65785
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods to inhibit the DNA-PK biological activity, methods to sensitize cells the agents that cause DNA lesions, and methods to potentiate cancer treatment are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.